Considering the inhibitory role of CD4+ T cells in the in- and outside of the TME through the paracrine signaling-driven support of CD8+ T cells within this milieu, these findings provide a potential mechanistic explanation of the correlation between peripheral blood immune cell LOY and negative outcome in some cancer patients. The gene discussed is CD8A; the disease is cancer.